Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation

被引：3
|
作者：
Kim, Bo Hyun [1 ]
Park, Joong-Won [1 ]
机构：
[1] Natl Canc Ctr, Ctr Liver Canc, 323 Ilsan Ro, Goyang 10408, South Korea
来源：
JOURNAL OF KOREAN MEDICAL SCIENCE | 2018年 / 33卷 / 45期
关键词：
D O I：
10.3346/jkms.2018.33.e286
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
    Yoon, Dok Hyun
    Ryoo, Baek-Yeol
    Ryu, Min-Hee
    Lee, Sung-Gyu
    Hwang, Shin
    Suh, Dong Jin
    Lee, Han Chu
    Kim, Tae Won
    Ahn, Chul-Soo
    Kim, Ki-Hun
    Moon, Deok-Bog
    Kang, Yoon-Koo
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (08) : 768 - 773
  • [2] Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation?
    Vitale, A.
    Boccagni, P.
    Kertusha, X.
    Zanus, G.
    D'Amico, F.
    Lodo, E.
    Pastorelli, D.
    Morales, R. Ramirez
    Lombardi, G.
    Senzolo, M.
    Burra, P.
    Cillo, U.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (07) : 1989 - 1991
  • [3] Sorafenib for recurrent hepatocellular carcinoma after liver transplantation.
    Ryoo, B.
    Yoon, D.
    Ryu, M.
    Lee, S.
    Hwang, S.
    Suh, D.
    Lee, J.
    Kim, T.
    Chang, H.
    Kang, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Sorafenib Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation
    Sotiropoulos, G. C.
    Nowak, K. W.
    Fouzas, I.
    Vernadakis, S.
    Kykalos, S.
    Klein, C. G.
    Paul, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2754 - 2756
  • [5] High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
    Staufer, Katharina
    Fischer, Lutz
    Seegers, Barbara
    Vettorazzi, Eik
    Nashan, Bjoern
    Sterneck, Martina
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 (11) : 1158 - 1164
  • [6] Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation
    de'Angelis, Nicola
    Landi, Filippo
    Nencioni, Marco
    Palen, Anais
    Lahat, Eylon
    Salloum, Chady
    Compagnon, Philippe
    Lim, Chetana
    Costentin, Charlotte
    Calderaro, Julien
    Luciani, Alain
    Feray, Cyrille
    Azoulay, Daniel
    [J]. PROGRESS IN TRANSPLANTATION, 2016, 26 (04) : 348 - 355
  • [7] Sorafenib for recurrent hepatocellular carcinoma after liver transplantation: Intrinsic resistance or not?
    Tovoli, Francesco
    Sansone, Vito
    Di Costanzo, Giovan Giuseppe
    Magini, Giulia
    Sacco, Rodolfo
    Pressiani, Tiziana
    Trevisani, Franco
    Tortora, Raffaella
    Bucci, Laura
    Luca, Maria Grazia
    Bolondi, Luigi
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E619 - E620
  • [8] Use of sorafenib in recurrent hepatocellular carcinoma (HCC) after liver transplantation
    Chiu, Joanne Wing-Yan
    Yau, Thomas Cheung
    Cheung, Tan To
    Chan, Albert
    Chok, Siu-Ho
    Dai, Wing-Chiu
    Leung, Roland Ching-Yu
    Chan, See-Ching
    Lo, Chung-Mau
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
    Waghray, Abhijeet
    Balci, Bengi
    El-Gazzaz, Galal
    Kim, Richard
    Pelley, Robert
    Menon, K. V. Narayanan
    Estfan, Bassam
    Romero-Marrero, Carlos
    Aucejo, Federico
    [J]. CLINICAL TRANSPLANTATION, 2013, 27 (04) : 555 - 561
  • [10] Safety and Efficacy of Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation
    Waghray, Abhijeet
    Balci, Bengi
    El-Gazzaz, Galal
    Miller, Charles M.
    Pelley, Robert J.
    Aucejo, Federico N.
    Menon, K. V. Narayanan
    [J]. HEPATOLOGY, 2012, 56 : 463A - 464A
12345